PRESS RELEASE published on 03/05/2025 at 15:52, 11 months 13 days ago Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors Oncodesign Precision Medicine appoints Christophe Thurieau, Executive Director Research at Servier, as an independent member of the Board of Directors for a four-year term. Thurieau brings over 35 years of healthcare expertise to OPM Board Of Directors Healthcare Christophe Thurieau Oncodesign Precision Medicine Servier
BRIEF published on 03/05/2025 at 15:52, 11 months 13 days ago Christophe Thurieau rejoint le Conseil d'Administration d'Oncodesign Precision Medicine Biotechnologie Conseil D'administration Nomination Christophe Thurieau Oncodesign Precision Medicine
BRIEF published on 03/05/2025 at 15:52, 11 months 13 days ago Christophe Thurieau joins the Board of Directors of Oncodesign Precision Medicine Board Of Directors Biotechnology Appointment Christophe Thurieau Oncodesign Precision Medicine
PRESS RELEASE published on 03/05/2025 at 15:47, 11 months 13 days ago Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors Nomination de Christophe Thurieau en tant qu’administrateur indépendant du Conseil d’Administration d’OPM. Christophe Thurieau, expert en Recherche et Développement Pharmaceutique, rejoindra OPM pour un mandat de 4 ans Biopharmaceutique Médecine De Précision Administrateur Indépendant OPM Christophe Thurieau
BRIEF published on 10/15/2024 at 08:05, 1 year 4 months ago OPM-101 Phase 1 Trial Results Presented at UEG Week 2024 Ulcerative Colitis Phase 1 Trial UEG Week 2024 OPM-101 Safety Profile
BRIEF published on 10/15/2024 at 08:05, 1 year 4 months ago Résultats de l'essai de phase 1 OPM-101 présentés à l'UEG Week 2024 Rectocolite Hémorragique Semaine UEG 2024 OPM-101 Essai De Phase 1 Profil De Sécurité
PRESS RELEASE published on 10/15/2024 at 08:00, 1 year 4 months ago Inside Information / Other news releases OPM presents safety & efficacy data on OPM-101, a novel RIPK2 kinase inhibitor, in healthy volunteers at UEG Week 2024 conference, targeting IBD treatment Precision Medicine UEG Week 2024 OPM-101 RIPK2 Kinase Inhibitor IBD Treatment
Published on 02/18/2026 at 15:15, 1 hour 43 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 1 hour 58 minutes ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 2 hours 33 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 2 hours 58 minutes ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 2 hours 58 minutes ago Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 15:50, 1 hour 8 minutes ago CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Published on 02/18/2026 at 15:48, 1 hour 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 02/18/2026 at 15:47, 1 hour 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Published on 02/18/2026 at 15:46, 1 hour 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd
Published on 02/18/2026 at 15:44, 1 hour 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC
Published on 02/18/2026 at 13:45, 3 hours 13 minutes ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
Published on 02/18/2026 at 11:00, 5 hours 58 minutes ago Mise à disposition des documents préparatoires à l'AG
Published on 02/18/2026 at 08:07, 8 hours 51 minutes ago TERACT - Modification du calendrier financier